Evaluation
*
Strongly disagreeDisagreeSlightly disagreeNeitherSlightly agreeAgreeStrongly agree
The activity presented balanced, evidence-based content free of commercial bias.
The presenter(s) used an effective teaching strategy.
The presentation slides / digital materials / resources and handouts were high quality.
The content was relevant to / useful for my professional practice.
The activity contributed to my knowledge, skills, and capacity to enhance the delivery of patient care.
The overall quality of the educational activity was excellent.
*
Strongly disagreeDisagreeSlightly disagreeNeitherSlightly agreeAgreeStrongly agree
Summarize efficacy, safety, and cardiovascular outcomes of GLP-1 and GIP/GLP-1 receptor agonists in obesity treatment.
Integrate women's health considerations (PCOS, Contraception, pre-contraception) into obesity pharmacotherapy.
Evaluate the impact on MHS: TRICARE coverage and deployment readiness.
*
*
*
*
*
*
*